South African tycoon Stephen Saad's Aspen receives $220 million for menopause drug sale
Aspen Pharmacare, led by South African tycoon Stephen Saad, has received €197 million from Ennogen and completed the sale of Ovestin in Europe.
Ennogen Healthcare International Ltd